Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma
Liren Zhang, Jiali Xu, Suiqing Zhou, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 82-98
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis
Kangnan Zhang, Zhenhua Zhu, Rongrong Jia, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
Cunzhen Zhang, Jiyao Wang, Lin Jia, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 236-236
Open Access
Clinical Translation of a Dual-Integrin αvβ3- and CD13-Targeting PET Tracer
Xiao Zhang, Biao Yang, Chunxia Qin, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Neutrophil extracellular traps in tumor metabolism and microenvironment
Z. Liu, Yuanyao Dou, Conghua Lu, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma
Huaiyu Wu, Shu-Ya Cao, Zhenggang Xu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
A Novel Gene Signature for Predicting Outcome in Colorectal Cancer Patients Based on Tumor Cell-Endothelial Cell Interaction via Single-Cell Sequencing and Machine Learning
Lina Pang, Qi Sun, Wenyue Wang, et al.
Heliyon (2025), pp. e42237-e42237
Open Access
Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
Zhenglin He, Yanhong Ji, Yutong Yuan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafenib responsive to post-embolization microenvironment
Xing Gao, Hongwei Cheng, Minglei Teng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 879-889
Closed Access
Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Role of Ubiquitination-driven Metabolisms in Oncogenesis and Cancer Therapy
Dongqin Yang, Can Yang, Linlin Huang, et al.
Seminars in Cancer Biology (2025)
Closed Access
NANOTECHNOLOGY-DRIVEN THERAPEUTICS FOR LIVER CANCER: CLINICAL APPLICATIONS AND PHARMACEUTICAL INSIGHTS
Lokeshvar Ravikumar, RAMAIYAN VELMURUGAN, Nithin Vidiyala, et al.
Asian Journal of Pharmaceutical and Clinical Research (2025), pp. 8-26
Open Access
Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
Fusheng Zhang, Yongsu Ma, Dongqi Li, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
CXCL12+ Tumor-associated Endothelial Cells Promote Immune Resistance in Hepatocellular Carcinoma.
Yajie Lu, Yunpeng Liu, Xiaoshuang Zuo, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 4
Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma
Ruizhi Zhang, Jingjing Dai, Feifan Yao, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109821-109821
Open Access | Times Cited: 3
Dicoumarol attenuates NLRP3 inflammasome activation to inhibit inflammation and fibrosis in knee osteoarthritis
Wenjie Ge, Xian Zhang, Qing Wang, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 2
Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy
Ying Wang, Longxiang Su, Zhansheng Hu, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1429-1453
Closed Access | Times Cited: 2
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges
Lin Gan, Weimin Wang, Jinxiu Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Hypoxia makes EZH2 inhibitor not easy—advances of crosstalk between HIF and EZH2
Z. Huang, Yuanjun Tang, Jianlin Zhang, et al.
Life Metabolism (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma
Wei Yan, Dean Rao, Feimu Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Integrated pan-cancer genomic analysis reveals the role of SLC30A5 in the proliferation, metastasis, and prognosis of hepatocellular carcinoma
Yihan Liu, Tong Lü, Runze Li, et al.
Journal of Cancer (2024) Vol. 15, Iss. 14, pp. 4686-4699
Open Access | Times Cited: 1
Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
Wenhua You, Chupeng Hu, Mengya Zhao, et al.
Gut (2024), pp. gutjnl-333375
Closed Access | Times Cited: 1
Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
Yipeng He, Tianbao Song, Jinzhuo Ning, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 1
Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application
Lin Su, Jiawen Bu, Jiahui Yu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top